| 1 |
Atif M, Munir K, Malik I, Al-Worafi YM, Mushtaq I, Ahmad N. Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study. Front Pharmacol 2022;13:965806. [PMID: 36588713 DOI: 10.3389/fphar.2022.965806] [Reference Citation Analysis]
|
| 2 |
Lara-Júnior CR, Ahouagi AEO, Pinto IVL, Braga DG, Andrade TR, Ramalho-de-Oliveira D, Nascimento MMGD. Implementation and Effectiveness of a Pharmacotherapeutic Follow-Up Service for People with Tuberculosis in Primary Healthcare. Int J Environ Res Public Health 2022;19. [PMID: 36361432 DOI: 10.3390/ijerph192114552] [Reference Citation Analysis]
|
| 3 |
Jarad S, Akour A, Khreisat WH, Elshammari AK, Madae’en S. The Role of Clinical Pharmacist in Pediatrics’ Adherence to Antiepileptic Drugs. Journal of Pharmacy Technology 2022;38:272-282. [DOI: 10.1177/87551225221097619] [Reference Citation Analysis]
|
| 4 |
Boursier A, Ferret L, Fulcrand J, Heiremans J, Charpentier P, Dujardin L, Lemaire A. Intégration de pharmaciens cliniciens au sein d’un Centre d’évaluation et de traitement de la douleur : retour d’expérience et perspectives. Le Pharmacien Clinicien 2022;57:28-34. [DOI: 10.1016/j.phclin.2021.05.004] [Reference Citation Analysis]
|
| 5 |
Tran CH, Moore BK, Pathmanathan I, Lungu P, Shah NS, Oboho I, Al-Samarrai T, Maloney SA, Date A, Boyd AT. Tuberculosis treatment within differentiated service delivery models in global HIV/TB programming. J Int AIDS Soc 2021;24 Suppl 6:e25809. [PMID: 34713974 DOI: 10.1002/jia2.25809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Pradipta IS, Idrus LR, Probandari A, Lestari BW, Diantini A, Alffenaar JC, Hak E. Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient's perspective. BMC Public Health 2021;21:1903. [PMID: 34670527 DOI: 10.1186/s12889-021-12005-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Kara E, Kelleci Çakır B, Sancar M, Demirkan K. Impact of Clinical Pharmacist-led Interventions in Turkey. Turk J Pharm Sci 2021;18:517-26. [PMID: 34496559 DOI: 10.4274/tjps.galenos.2020.66735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Rahhal A, Mahfouz A, Al‐amri M, Aljundi A, Khir F, Hamid Y, Alyafei S, Arabi AR. Impact of discharge education by clinical pharmacists on patients' adherence to post‐percutaneous coronary intervention medications: A retrospective cohort study using real‐world data. J Am Coll Clin Pharm 2021;4:303-310. [DOI: 10.1002/jac5.1369] [Reference Citation Analysis]
|
| 9 |
Adepoju AV, Ogbudebe CL, Adejumo OA, Okolie J, Inegbeboh JO. Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors. J Glob Infect Dis 2020;12:105-11. [PMID: 32773999 DOI: 10.4103/jgid.jgid_138_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Katiyar S, Katiyar S. Protocol for the management of newly diagnosed cases of tuberculosis. Indian Journal of Tuberculosis 2019;66:507-515. [DOI: 10.1016/j.ijtb.2019.11.003] [Reference Citation Analysis]
|
| 11 |
Bezerra SS, Guerreiro MP, Pessoa NF, Silva MGPD, Barros MGD, Gomes JJF, Athayde MP, Auad RZ, Soares Sobrinho JL. The Perspectives of Patients and Health Professionals Regarding the Tuberculosis Control Programme in Recife, Brazil: A Contribution to Evaluation. Pharmacy 2019;7:70. [DOI: 10.3390/pharmacy7020070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 12 |
Riquelme-Miralles D, Palazón-Bru A, Sepehri A, Gil-Guillén VF. A systematic review of non-pharmacological interventions to improve therapeutic adherence in tuberculosis. Heart Lung 2019;48:452-61. [PMID: 31084923 DOI: 10.1016/j.hrtlng.2019.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 13 |
Werremeyer A, Orr M. Pharmacist‐led medication education groups on an inpatient psychiatric unit—Impact on readmissions and emergency department visits. J Am Coll Clin Pharm 2019;2:228-35. [DOI: 10.1002/jac5.1060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 14 |
van de Berg S, Jansen-Aaldring N, de Vries G, van den Hof S. Patient support for tuberculosis patients in low-incidence countries: A systematic review. PLoS One 2018;13:e0205433. [PMID: 30304052 DOI: 10.1371/journal.pone.0205433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 15 |
Jansen‐aaldring N, Berg S, Hof S. Patient support during treatment for active tuberculosis and for latent tuberculosis infection: Policies and practices in European low‐incidence countries. J Adv Nurs 2018;74:2755-65. [DOI: 10.1111/jan.13784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Tang ZQ, Jiang RH, Xu HB. Effectiveness of pharmaceutical care on treatment outcomes for patients with first-time pulmonary tuberculosis in China. J Clin Pharm Ther 2018;43:888-94. [PMID: 30003561 DOI: 10.1111/jcpt.12746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 17 |
Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, Nahid P. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med 2018;15:e1002595. [PMID: 29969463 DOI: 10.1371/journal.pmed.1002595] [Cited by in Crossref: 162] [Cited by in F6Publishing: 111] [Article Influence: 32.4] [Reference Citation Analysis]
|
| 18 |
Guix-Comellas EM, Rozas-Quesada L, Velasco-Arnaiz E, Ferrés-Canals A, Estrada-Masllorens JM, Force-Sanmartín E, Noguera-Julian A. Impact of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: A nonrandomized controlled trial. J Adv Nurs 2018. [PMID: 29726024 DOI: 10.1111/jan.13692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 19 |
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016;63:853-67. [PMID: 27621353 DOI: 10.1093/cid/ciw566] [Cited by in Crossref: 167] [Cited by in F6Publishing: 179] [Article Influence: 27.8] [Reference Citation Analysis]
|
| 20 |
Lopes AR, Miranda SSD, Ceccato MDGB, Silveira MR, Resende NHD, Carvalho WS. Evaluation of the impact of pharmaceutical care for tuberculosis patients in a Secondary Referral Outpatient Clinic, Minas Gerais, Brazil. An Acad Bras Ciênc 2017;89:2911-9. [DOI: 10.1590/0001-3765201720170301] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 21 |
Shao H, Chen G, Zhu C, Chen Y, Liu Y, He Y, Jin H. Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus. Patient Prefer Adherence 2017;11:897-903. [PMID: 28507433 DOI: 10.2147/PPA.S92533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 22 |
Tanvejsilp P, Pullenayegum E, Loeb M, Dushoff J, Xie F. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand. J Clin Pharm Ther 2017;42:337-44. [PMID: 28317143 DOI: 10.1111/jcpt.12519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Guix-comellas EM, Rozas-quesada L, Morín-fraile V, Estrada-masllorens JM, Galimany-masclans J, Sancho-agredano R, Ferrés-canals A, Force-sanmartín E, Noguera-julian A. Educational Measure for Promoting Adherence to Treatment for Tuberculosis. Procedia - Social and Behavioral Sciences 2017;237:705-9. [DOI: 10.1016/j.sbspro.2017.02.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016;63:e147-95. [PMID: 27516382 DOI: 10.1093/cid/ciw376] [Cited by in Crossref: 582] [Cited by in F6Publishing: 626] [Article Influence: 83.1] [Reference Citation Analysis]
|
| 25 |
Wiener ES, Mullins CD, Pincus KJ. A framework for pharmacist-assisted medication adherence in hard-to-reach patients. Research in Social and Administrative Pharmacy 2015;11:595-601. [DOI: 10.1016/j.sapharm.2014.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 26 |
Macit C. The Effect of Pharmacist-Led Education on the Quality of Life of Children with Familial Mediterranean Fever. PPIJ 2015;2. [DOI: 10.15406/ppij.2015.02.00020] [Reference Citation Analysis]
|
| 27 |
Wiedenmayer KA, Kapologwe N, Charles J, Chilunda F, Mapunjo S. The reality of task shifting in medicines management- a case study from Tanzania. J Pharm Policy Pract 2015;8:13. [PMID: 25893096 DOI: 10.1186/s40545-015-0032-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 28 |
Guix-Comellas EM, Rozas-Quesada L, Force-Sanmartín E, Estrada-Masllorens JM, Galimany-Masclans J, Noguera-Julian A. Influence of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: research protocol. J Adv Nurs 2015;71:2189-99. [PMID: 25818512 DOI: 10.1111/jan.12656] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Okabe T. Effective Use of Computed Tomography to Distinguish an Insurmountable Tortuosity of the Common Iliac Artery During the Trans-Femoral Approach. JCCR 2014;1. [DOI: 10.15406/jccr.2014.01.00031] [Reference Citation Analysis]
|
| 30 |
Johari M, Eslami AA, Alahverdipoor H, Hasanzade A, Farid F. Factors related to adopting healthy behaviors by patients with tuberculosis in Isfahan: Application of health belief model. J Educ Health Promot 2014;3:86. [PMID: 25250352 DOI: 10.4103/2277-9531.139600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 31 |
Bender BG, Oppenheimer J. The special challenge of nonadherence with sublingual immunotherapy. J Allergy Clin Immunol Pract 2014;2:152-5. [PMID: 24607041 DOI: 10.1016/j.jaip.2014.01.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 32 |
Norman S, Davis E, Goldstone LW, Villa L, Warholak TL. A Rasch analysis of a questionnaire designed to evaluate psychiatric patient attitudes and knowledge after attending a pharmacist-led patient medication education group. Res Social Adm Pharm 2014;10:867-76. [PMID: 24746029 DOI: 10.1016/j.sapharm.2014.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 33 |
Muñoz EB, Dorado MF, Guerrero JE, Martínez FM. The effect of an educational intervention to improve patient antibiotic adherence during dispensing in a community pharmacy. Aten Primaria 2014;46:367-75. [PMID: 24581680 DOI: 10.1016/j.aprim.2013.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 34 |
Ballantyne PJ. Pharmacists in Patient Outcomes, Role of. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society 2014. [DOI: 10.1002/9781118410868.wbehibs131] [Reference Citation Analysis]
|
| 35 |
Jackson AN, Kelly Orr K, Bratberg JP, Silverblatt F. Pharmacist initiation of postexposure doxycycline for Lyme disease prophylaxis. Journal of the American Pharmacists Association 2014;54:69-73. [DOI: 10.1331/japha.2014.13106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 36 |
Palmero D, Ritacco V. Clinical Management of Drug-Resistant Tuberculosis in Resource Constrained Settings. Clinical Medicine Insights: Therapeutics 2013;5:CMT.S6560. [DOI: 10.4137/cmt.s6560] [Reference Citation Analysis]
|
| 37 |
M'imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev 2012;:CD006591. [PMID: 22592714 DOI: 10.1002/14651858.CD006591.pub2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 66] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Okuyan B, Sancar M, Izzettin FV. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings: ASSESSMENT OF MEDICATION KNOWLEDGE AND ADHERENCE. Pharmacoepidemiol Drug Saf 2013;22:209-14. [DOI: 10.1002/pds.3275] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 39 |
Suwannakeeree W, Picheansathian W. Strategies to Promote Adherence to Treatment by Pulmonary Tuberculosis Patients: A systematic review. JBI Libr Syst Rev 2012;10:615-78. [PMID: 27820545 DOI: 10.11124/jbisrir-2012-64] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 40 |
Cobelens F, van Kampen S, Ochodo E, Atun R, Lienhardt C. Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review. PLoS Med 2012;9:e1001358. [PMID: 23271959 DOI: 10.1371/journal.pmed.1001358] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 41 |
Orr P. Adherence to tuberculosis care in Canadian Aboriginal populations, Part 2: a comprehensive approach to fostering adherent behaviour. Int J Circumpolar Health 2011;70:128-40. [PMID: 21524358 DOI: 10.3402/ijch.v70i2.17810] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 42 |
Gnanasan S, Ting KN, Wong KT, Mohd Ali S, Muttalif AR, Anderson C. Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care. Int J Clin Pharm 2011;33:44-52. [PMID: 21365392 DOI: 10.1007/s11096-010-9452-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 43 |
James S, Watson M. Mycobacterium tuberculosis: implications for district nurses. Br J Community Nurs 2010;15:492-5. [PMID: 20966844 DOI: 10.12968/bjcn.2010.15.10.78732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 44 |
Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci. 2009;31:689-695. [PMID: 19777365 DOI: 10.1007/s11096-009-9333-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 45 |
Lee VWY, Fan CSY, Li AWM, Chau ACY. Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong. Journal of Clinical Pharmacy and Therapeutics 2009;34:407-14. [DOI: 10.1111/j.1365-2710.2009.01024.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 46 |
Divine HS, Cain J. Assessing the Effect of a Polypharmacy Medication Adherence Simulation Project in a Geriatrics Course in a College of Pharmacy: MEDICATION ADHERENCE PROJECT IN A GERIATRICS COURSE. Journal of the American Geriatrics Society 2009;57:1487-91. [DOI: 10.1111/j.1532-5415.2009.02364.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 47 |
Shih V, Wan HS, Chan A. Clinical Predictors of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Doxorubicin and Cyclophosphamide. Ann Pharmacother 2009;43:444-52. [DOI: 10.1345/aph.1l437] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 48 |
Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol 2009;67:547-57. [PMID: 19552750 DOI: 10.1111/j.1365-2125.2009.03391.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 49 |
Mitrzyk BM. Treatment of Extensively Drug-Resistant Tuberculosis and Role of the Pharmacist. Pharmacotherapy 2008;28:1243-54. [DOI: 10.1592/phco.28.10.1243] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Chisholm-Burns MA, Spivey CA, Garrett C, McGinty H, Mulloy LL. Impact of clinical pharmacy services on renal transplant recipients’ adherence and outcomes. Patient Prefer Adherence. 2008;2:287-292. [PMID: 19920975 DOI: 10.2147/ppa.s4174] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
|
